Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 12, 2016 - Issue 9
Submit an article Journal homepage
1,306
Views
9
CrossRef citations to date
0
Altmetric
Short Report

Cost-effectiveness of a herpes zoster vaccination program among the French elderly people

Emmanuel BelchiorSanté Publique France, French National Public Health Agency, Saint-Maurice, FranceCorrespondence[email protected]
,
Daniel Lévy-BruhlSanté Publique France, French National Public Health Agency, Saint-Maurice, France
,
Yann Le StratSanté Publique France, French National Public Health Agency, Saint-Maurice, France
&
Magid HeridaSanté Publique France, French National Public Health Agency, Saint-Maurice, France
Pages 2378-2382 | Received 31 Dec 2015, Accepted 26 Apr 2016, Published online: 02 Aug 2016

References

  • Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58:9-20; PMID:14267505
  • Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract 1975; 25(157):571-5; PMID:1195231
  • Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996; 67(2-3):241-51; PMID:8951917; http://dx.doi.org/10.1016/0304-3959(96)03122-3
  • Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352(22):2271-84; PMID:15930418; http://dx.doi.org/10.1056/NEJMoa051016
  • van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ. Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine 2009; 27(9):1454-67; PMID:19135492; http://dx.doi.org/10.1016/j.vaccine.2008.12.024
  • Morrison VA, Johnson GR, Schmader KE, Levin MJ, Zhang JH, Looney DJ, Betts R, Gelb L, Guatelli JC, Harbecke R, et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis 2015; 60(6):900-9; PMID:25416754; http://dx.doi.org/10.1093/cid/ciu918
  • Bresse X, Annemans L, Preaud E, Bloch K, Duru G, Gauthier A. Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis. Expert Rev Pharmacoecon Outcomes Res 2013; 13(3):393-406; PMID:23537397; http://dx.doi.org/10.1586/erp.13.19
  • Gonzalez Chiappe S, Sarazin M, Turbelin C, Lasserre A, Pelat C, Bonmarin I, Chosidow O, Blanchon T, Hanslik T. Herpes zoster: burden of disease in France. Vaccine 2010; 28(50):7933-8; PMID:20946861; http://dx.doi.org/10.1016/j.vaccine.2010.09.074
  • Mick G, Gallais JL, Simon F, Pinchinat S, Bloch K, Beillat M, Serradell L, Derrough T. [Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over]. Rev Epidemiol Sante Publique 2010; 58(6):393-401; PMID:21094001; http://dx.doi.org/10.1016/j.respe.2010.06.166
  • Bouhassira D, Chassany O, Gaillat J, Hanslik T, Launay O, Mann C, Rabaud C, Rogeaux O, Strady C. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain 2012; 153(2):342-9; PMID:22138256; http://dx.doi.org/10.1016/j.pain.2011.10.026
  • Blein C, Gavazzi G, Paccalin M, Baptiste C, Berrut G, Vainchtock A. Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France. BMC Infect Dis 2015; 15(1):350; PMID:26286598; http://dx.doi.org/10.1186/s12879-015-1059-9
  • Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health 2015; 15:533; PMID:26041469; http://dx.doi.org/10.1186/s12889-015-1861-8
  • Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine 2014; 32(15):1645-53; PMID:24534737; http://dx.doi.org/10.1016/j.vaccine.2014.01.058
  • Haut Conseil de la Santé Publique. Vaccination des adultes contre le zona: place du vaccin Zostavax® [Internet]. Paris: Haut Conseil de la Santé Publique, 2013 10/25/2013.
  • Haute Autorité de Santé. Choix méthodologiques pour l’évaluation économique à la HAS. Saint-Denis La Plaine: Haute Autorité de Santé, 2011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.